APA (7th ed.) Citation

Li, Y., Zhang, T., Zhang, J., Liu, Q., Jia, Q., Chen, W., . . . He, J. (2023). Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis. Biomaterials, 301, 122232. https://doi.org/10.1016/j.biomaterials.2023.122232

Chicago Style (17th ed.) Citation

Li, Yanping, et al. "Dually Fibronectin/CD44-mediated Nanoparticles Targeted Disrupt the Golgi Apparatus and Inhibit the Hedgehog Signaling in Activated Hepatic Stellate Cells to Alleviate Liver Fibrosis." Biomaterials 301 (2023): 122232. https://doi.org/10.1016/j.biomaterials.2023.122232.

MLA (9th ed.) Citation

Li, Yanping, et al. "Dually Fibronectin/CD44-mediated Nanoparticles Targeted Disrupt the Golgi Apparatus and Inhibit the Hedgehog Signaling in Activated Hepatic Stellate Cells to Alleviate Liver Fibrosis." Biomaterials, vol. 301, 2023, p. 122232, https://doi.org/10.1016/j.biomaterials.2023.122232.